Pluristem (PSTI) - Net Assets

Latest as of March 2022: ILA40.14 Million ILA ≈ $107.62K USD

Based on the latest financial reports, Pluristem (PSTI) has net assets worth ILA40.14 Million ILA (≈ $107.62K USD) as of March 2022. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA79.13 Million ≈ $212.14K USD) and total liabilities (ILA38.98 Million ≈ $104.51K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Pluristem liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	ILA40.14 Million
% of Total Assets	50.73%
Annual Growth Rate	-1.18%
5-Year Change	88.92%
10-Year Change	N/A
Growth Volatility	61.24

Pluristem - Net Assets Trend (2014–2021)

This chart illustrates how Pluristem's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Pluristem for the complete picture of this company's asset base.

Annual Net Assets for Pluristem (2014–2021)

The table below shows the annual net assets of Pluristem from 2014 to 2021. For live valuation and market cap data, see Pluristem market capitalisation.

Year	Net Assets	Change
2021-06-30	ILA57.15 Million ≈ $153.22K	+1.87%
2020-06-30	ILA56.10 Million ≈ $150.40K	+157.10%
2019-06-30	ILA21.82 Million ≈ $58.50K	-23.45%
2018-06-30	ILA28.51 Million ≈ $76.43K	-5.77%
2017-06-30	ILA30.25 Million ≈ $81.10K	-20.72%
2016-06-30	ILA38.16 Million ≈ $102.29K	-34.38%
2015-06-30	ILA58.14 Million ≈ $155.88K	-6.41%
2014-06-30	ILA62.12 Million ≈ $166.55K	--

Equity Component Analysis

This analysis shows how different components contribute to Pluristem's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 21618700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2021)

Component	Amount	Percentage
Other Components	ILA387.17 Million	677.45%
Total Equity	ILA57.15 Million	100.00%

Pluristem Competitors by Market Cap

The table below lists competitors of Pluristem ranked by their market capitalization.

Company	Market Cap
Taiwan Alpha Electronic Co Ltd TWO:6204	$65.51 Million
Al-Salam Real Estate Investment Trust KLSE:5269	$65.53 Million
Hunya Foods Co Ltd TW:1236	$65.54 Million
Salcon Engineering Berhad KLSE:8567	$65.56 Million
Thitikorn Public Company Limited BK:TK	$65.46 Million
Fine Blanking & Tool Co Ltd TWO:4535	$65.43 Million
Dawonsys Co.Ltd KQ:068240	$65.43 Million
Song Shang Electronics Co Ltd TWO:6156	$65.42 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Pluristem's equity between the two most recent reporting periods.

Equity Growth Insights

From 2020 to 2021, total equity changed from 56,101,000 to 57,151,000, a change of 1,050,000 (1.9%).
Net loss of 49,865,000 reduced equity.
New share issuances of 36,589,000 increased equity.
Other factors increased equity by 14,326,000.

Equity Change Factors (2020 to 2021)

Factor	Impact	Contribution
Net Income	ILA-49.87 Million	-87.25%
Share Issuances	ILA36.59 Million	+64.02%
Other Changes	ILA14.33 Million	+25.07%
Total Change	ILA-	1.87%

Book Value vs Market Value Analysis

This analysis compares Pluristem's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 422.13x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has increased from 241.91x to 422.13x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-06-30	ILA3.12	ILA754.90	x
2018-06-30	ILA2.51	ILA754.90	x
2019-06-30	ILA1.45	ILA754.90	x
2020-06-30	ILA2.20	ILA754.90	x
2021-06-30	ILA1.79	ILA754.90	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Pluristem utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -87.25%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.00%
• Asset Turnover: 0.00x
• Equity Multiplier: 1.64x
Recent ROE (-87.25%) is below the historical average (-78.92%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	-43.35%	-7106.07%	0.01x	1.19x	ILA-33.14 Million
2015	-42.44%	-6511.08%	0.01x	1.17x	ILA-30.49 Million
2016	-60.92%	-816.51%	0.06x	1.20x	ILA-27.06 Million
2017	-91.94%	0.00%	0.00x	1.24x	ILA-30.84 Million
2018	-91.65%	-52252.00%	0.00x	1.37x	ILA-28.98 Million
2019	-161.80%	-65383.33%	0.00x	1.43x	ILA-37.49 Million
2020	-51.96%	-126747.83%	0.00x	1.17x	ILA-34.76 Million
2021	-87.25%	0.00%	0.00x	1.64x	ILA-55.58 Million

Industry Comparison

This section compares Pluristem's net assets metrics with peer companies in the Biotechnology & Medical Research industry.

Industry Context

Industry: Biotechnology & Medical Research
Average net assets among peers: $19,273,000
Average return on equity (ROE) among peers: -44.49%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Pluristem (PSTI)	ILA40.14 Million	-43.35%	0.97x	$65.47 Million
Hadasit Bio (HDST)	$35.08 Million	-88.98%	0.11x	$2.16 Million
Purple Biotech Ltd (KTOV)	$3.47 Million	0.00%	1.20x	$461.41K

About Pluristem

TA:PSTI Israel Biotechnology & Medical Research

Market Cap

$65.47 Million

ILA24.42 Billion ILA

Market Cap Rank

#20955 Global

#284 in Israel

Share Price

ILA754.90

Change (1 day)

-4.71%

52-Week Range

ILA754.90 - ILA1900.00

All Time High

ILA72010.00